From MB,
Action and recommendation
• Maintain Outperform: A strong result, with growth in all key metrics YoY. The
outlook remains positive in 2HFY21, with production expected to be at the top
end of guidance. The release of the T3 optimised feasibility study was a
positive, providing visibility to operations beyond DeGrussa. SFR’s earnings
upgrade momentum is strong with spot prices generating 30% and 275%
higher earnings for FY21 and FY22.
- Forums
- ASX - By Stock
- Highest Copper Price Since 2011
From MB,Action and recommendation• Maintain Outperform: A strong...
- There are more pages in this discussion • 112 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SFR (ASX) to my watchlist
(20min delay)
|
|||||
Last
$9.67 |
Change
0.270(2.87%) |
Mkt cap ! $4.422B |
Open | High | Low | Value | Volume |
$9.50 | $9.80 | $9.48 | $16.43M | 1.702M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 13201 | $9.65 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$9.67 | 20000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 13201 | 9.650 |
5 | 11436 | 9.640 |
2 | 7596 | 9.630 |
1 | 4583 | 9.620 |
2 | 5279 | 9.610 |
Price($) | Vol. | No. |
---|---|---|
9.670 | 20000 | 1 |
9.690 | 978 | 1 |
9.710 | 2200 | 1 |
9.720 | 7353 | 3 |
9.730 | 4969 | 1 |
Last trade - 16.10pm 06/05/2024 (20 minute delay) ? |
|
|||||
Last
$9.69 |
  |
Change
0.270 ( 2.97 %) |
|||
Open | High | Low | Volume | ||
$9.50 | $9.80 | $9.49 | 952292 | ||
Last updated 15.59pm 06/05/2024 ? |
Featured News
SFR (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, CEO
Steven Gourlay
CEO
Previous Video
Next Video
SPONSORED BY The Market Online